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Abstract
Aims The clinical reliability of echocardiographic surrogate markers of left ventricular filling pressures (LVFPs) across differ-
ent cardiovascular pathologies remains unanswered. The main objective was to evaluate the evidence of how effectively dif-
ferent echocardiographic indices estimate true LVFP.
Methods and results Design: this is a systematic review and meta‐analysis. Data source: Scopus, PubMed and Embase. Eli-
gibility criteria for selecting studies were those that used echocardiography to predict or estimate pulmonary capillary wedge
pressure or left ventricular end‐diastolic pressures. Twenty‐seven studies met criteria. Only eight studies (30%) reported both
correlation coefficient and bias between non‐invasive and invasively measured LVFPs. The majority of studies (74%) recorded
invasive pulmonary capillary wedge pressure as a surrogate for left ventricular end‐diastolic pressures. The pooled correlation
coefficient overall was r = 0.69 [95% confidence interval (CI) 0.63–0.75, P < 0.01]. Evaluation by cohort demonstrated varying
association: heart failure with preserved ejection fraction (11 studies, n = 575, r = 0.59, 95% CI 0.53–0.64) and heart failure
with reduced ejection fraction (8 studies, n = 381, r = 0.67, 95% CI 0.61–0.72).
Conclusions Echocardiographic indices show moderate pooled association to invasively measured LVFP; however, this varies
widely with disease state. In heart failure with preserved ejection fraction, no single echocardiography‐based metric offers a
reliable estimate. In heart failure with reduced ejection fraction, mitral inflow‐derived indices (E/e′, E/A, E/Vp, and EDcT) have
reasonable clinical applicability. While an integrated approach of several echocardiographic metrics provides the most promise
for estimating LVFP reliably, such strategies need further validation in larger, patient‐specific studies.
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Introduction
The primary pathophysiological process in heart failure (HF) is
raised intracardiac pressure.1 For most patients with HF, this
is associated with increased left ventricular filling pressure
(LVFP) or left ventricular end‐diastolic pressure (LVEDP),
caused by either systolic or diastolic impairment of the left
ventricle (LV).2 LVEDP, a strong predictor of morbidity and
mortality, has long been regarded as the key measurement
for raised LVFP.2–4 Early diagnosis of raised LVFP is critical
to inform the diagnosis of HF and also guide treatment
optimization.5
The current standard approach to LVFP or LVEDP estima-
tion is by transthoracic echocardiography (TTE). TTE allows
for a detailed assessment of both LV diastolic and systolic
function (Figure 1).
Transthoracic echocardiography methods including mitral
inflow, tissue Doppler annular velocities, tricuspid regurgita-
tion velocity (TRV), and left atrial volume (LAV) have been
widely studied to estimate LVFP. In particular, E/e′ has been
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Figure 1 Case examples of Doppler‐based methods for left ventricular filling pressure (LVFP) assessment. The first case (green panel) is a healthy 20‐
year‐old male; the second case (yellow panel) is a 60‐year‐old male patient admitted with heart failure (HF). In the healthy adult case, the E/e′ is <8
and suggests normal LVFP vs. in the patient, it is >12 and suggests raised LVFP.
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the main focus of the majority of these studies. The current
recommendations advocate sub‐categorization of patients de-
pending on LV ejection fraction (LVEF). For patients with re-
duced LVEF (<50%), they recommend a focus on E/A ratio to
estimate LVFP. And for those with preserved LVEF (>50%), a
combination of E/e′, e′ velocity, TRV, and left atrial volume
indexed for body surface area (LAVi) is advised to predict
LVFP.6
The combined diagnostic accuracy of these TTE methods,
to predict LVEDP in different HF states, including heart failure
with preserved ejection fraction (HFpEF), heart failure with
reduced ejection fraction (HFrEF), and even in valvular heart
disease remains unclear. Systematic evidence synthesis is re-
quired to develop further understanding of which TTE
methods are clinically applicable to predict LVFP in a specific
HF state.
The aim of this systematic review and meta‐analysis was,
therefore, to summarize current literature, systematically
consolidate studies that have estimated LVEDP using TTE,
and ascertain their predictive association with invasive mea-
surements in different HF states.
Methods
Systematic review and meta‐analysis registration
This project was registered (CRD42020164642) with, and the
ethics approved by, the prospective register of systematic re-
view (PROSPERO).
Eligibility criteria
Eligible studies were those that used TTE to predict or esti-
mate pulmonary capillary wedge pressure (PCWP) or LVEDP.
The primary endpoint was the agreement between invasive
and non‐invasive methods. This was evaluated by both the
correlation coefficient and statistical bias in the respective
studies. This study mainly focused on the correlation coeffi-
cient (r), and all subsequent meta‐analyses were planned
using r values. We limited our search to peer‐reviewed
journals, medicine, and human adult (age ≥18 years) partici-
pants. Studies with fewer than 12 patients were excluded.
Search strategy
The Scopus database, which incorporates all MEDLINE and
Embase results, formed the basis of the literature search,
undertaken on 21 November 2019. Search terms included ‘in-
vasive’, ‘noninvasive/echocardiography’, and ‘LVEDP/Pulmo-
nary Capillary Wedge Pressure/PCWP’. The full search
strategy is included in the supporting information. An
identical search of the Cochrane Central database returned
no additional results. An extensive review of the referenced
literature identified 11 additional studies. Duplicate results
(n = 1) were removed, and the remaining results were com-
bined (n = 207).
Study selection
Preliminary vetting of the results, according to the Preferred
Reporting Items for Systematic Reviews and Meta‐Analyses
(PRISMA) guidelines, was undertaken by R. J. The shortlist
was subsequently reviewed by an independent assessor,
P. G. A third independent expert, A. J. S., was involved to
resolve disagreements. The PRISMA flow chart is detailed in
Figure 2.
Assessment of clinical applicability
We adapted the Critical Appraisal Skills Programme (CASP)
tool to ensure clinical applicability to the evidence synthe-
sis. This is detailed in the Supporting Information, Tables
S1 and S2.
Statistical analysis and meta‐analysis
Statistical analysis was performed using MedCalc (MedCalc
Software, Belgium, Version 19.1.5). We pooled the values of
correlation coefficients and numbers recruited in each study
for agreement between invasive and non‐invasive LVFPs. De-
tailed statistical methods are described in the supporting
information.
Results
The initial search identified 197 studies. A further 11
studies were identified through a thorough review of the
referenced literature. After an initial screening of title and
abstract, 34 research outcome papers were evaluated, and
from these, 27 articles met the inclusion criteria7–32
(Figure 2). The total number of patients studied across all
the 27 studies was 2058.
Study characteristics
All studies were diagnostic cohort studies, using the invasive
haemodynamic study as the reference test for LVFP. Consec-
utive patient recruitment was reported in 17 studies. Except
for Nagueh et al.27 and Andersenet al.,32 all studies were sin-
gle tertiary centre studies. All studies were published be-
tween 1997 and 2019. While some studies focused on
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specific disease states such as HFrEF (n = 8) and HFpEF (n =
11), some recruited heterogeneous patient populations (n =
11). From the 27 studies, only 8 studies (30%) reported both
correlation coefficient and bias (Supporting Information,
Table S3). The majority of studies (74%, 20/27) recorded inva-
sive PCWP as a surrogate for LVEDP. Seven studies recorded
LVEDP directly.10,14,18,22,24,30,31
Meta‐analysis results for all studies
The pooled analysis across all studies showed a statistically
significant association of invasive haemodynamic assessment
to echocardiographic methods—the weighted average
(random effects) correlation coefficient for all the 27 studies
was 0.69 [95% confidence interval (CI) 0.63–0.75, P < 0.01]
(Supporting Information, Table S4). Figure 3 shows the forest
plot of the pooled correlation coefficients, CIs, and percent-
age weighting for all studies included. Visual scrutiny of the
forest plots suggests that a degree of between‐study varia-
tion exists in terms of the effect sizes. I2 values of 81.6% con-
firmed significant levels of heterogeneity.
Temporelli et al. demonstrated the highest correlation
coefficient with invasive measurement (r = 0.92, 95% CI
0.86–0.96), using an integrated mitral inflow velocity (MIV)
equation (Figure 3).29 However, they recruited only 43 pa-
tients, reducing the overall weight of the study. The study
by Anderson et al. had the highest weight, closely followed
by the Lundberg et al. work into left atrial (LA) strain.32,33
Eight studies reported bias in the agreement between
echocardiographic modelled LVFP vs. invasively measured
LVFP. The maximum bias (bias = 9 mmHg) was reported by
Maeder et al. in an HFpEF cohort (Supporting Information,
Table S3).19 In HFrEF, the bias was comparatively less for
the two studies by Cameli et al. and Temporelli et al.16,29
Meta‐analysis results for echocardiography
metric
The first group, MIVs, had a pooled (random effects) correla-
tion coefficient of 0.58 (95% CI 0.46–0.68, P< 0.01) (Figure 4,
Supporting Information, Table S5). Four MIV studies
Figure 2 Search strategy flow chart as per the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses 2009 guidance.
4 R. Jones et al.
ESC Heart Failure (2020)
DOI: 10.1002/ehf2.13119
Figure 3 (A) Forest plot of all the 23 studies evaluated in meta‐analysis for non‐invasive assessment of left ventricular filling pressure. (B) Funnel plot
of all the 23 studies.
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comprised a heterogeneous patient population: two studies
investigated HFrEF (n = 91), and two investigated coronary
artery disease (CAD) (n = 56). The study with the highest
correlation was that by Martins et al. (r = 0.90, 95% CI
0.71–0.97).11 However, this study had the lowest weighting
within this category, recruiting only 14 patients. The most
highly weighted study was that by Anderson et al.
(n = 450), showing moderate association between E/A and
Figure 4 Forest plots of all the methods applied by echocardiography for non‐invasive assessment of left ventricular filling pressure.
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invasive LVFP (r = 0.53).32 The most widely studied MIV pa-
rameter was E/A (n = 665). Other echocardiography metrics
studied included E/Vp (n = 85) and EDcT (n = 64).
The second category, E/e′, was the largest, incorporating
17 studies and 1348 patients [HFpEF, n = 253; HFrEF,
n = 126; heterogeneous, n = 785; aortic stenosis (AS),
n = 28; mitral regurgitation (MR), n = 108]. E/e′ had a pooled
random effects correlation coefficient of 0.55 (95% CI 0.46–
0.62, P < 0.01, z = 11). Correlation coefficients varied greatly
between studies, ranging from 0.08 (95% CI 0.38 to 0.5)
(Hewing et al.) to 0.84 (95% CI 0.65–0.93) (Kasner et al.).22,24
The Kawase et al. study investigating E/e′ in MR patients
(r = 0.33) recruited 108 patients, contributing significant
weight in reducing the pooled correlation coefficient.23
The third major parameter studied was LA size and func-
tion. Overall, these studies had a pooled random effects
correlation of 0.56 (95% CI 0.47–0.64, P < 0.01, z = 10,
n = 952). Of these, LAVi was investigated in five studies, in-
cluding 357 patients; LA area was also investigated in 144
patients, and LA strain assessments were undertaken in
280 patients. One study evaluated LAVi in MR cases
(n = 108) and found a correlation coefficient of 0.55 (95%
CI 0.40–0.67) (Kawase et al.), much stronger than that
found for LA area alone (r = 0.33, 95% CI 0.00–0.59).23 Of
the LA parameters, LA strain assessment had the strong
correlations, ranging from 0.46 (Lundberg et al.) to 0.81
(Cameli et al.).
Assessment of the right heart comprised three studies and
is the most novel category, with all studies published since
2017. These studies combined had a strong correlation coef-
ficient of 0.69 (95% CI 0.52–0.811 P < 0.01, z = 6.1, n = 747).
The largest study was by Anderson et al., investigating sys-
tolic pulmonary artery pressure (r = 0.58, 95% CI 0.52–
0.64).32 Nagueh et al.27 and de Scordilli et al. investigated
right atrial pressure, with the latter also studying TRV.28
TRV had a stronger correlation (r = 0.86, 95% CI 0.79–0.91),
compared with right atrial pressure; however, this is
weighted lower due to fewer patient numbers. All studies re-
cruited heterogeneous populations. The five integrated ap-
proach studies (n = 287) combined several
echocardiographic parameters into equations (Table 1) to es-
timate LVFP. This category had the highest weighted average
(random effects) correlation coefficient at 0.79 (95% CI 0.64–
0.88, P < 0.001, z = 6.84). Ommen et al. had the highest
weighting at 28.6% (n = 100) but also had the lowest correla-
tion of all the equations (r = 0.62, 95% CI 0.48–0.73) and the
lowest clinical applicability of all studies.10 In comparison,
Temporelli et al. found a correlation of 0.92 (95% CI 0.86–
0.96) using an equation focusing on MIV and had excellent
clinical applicability.29 The integrated approach studies incor-
porated a range of patient cohorts; Nagueh et al. and
Gonzalez‐Vilchez et al. studied heterogeneous populations
(n = 95), Ommen et al. and Temporelli et al. recruited HFrEF
patients (n = 63), Ommen et al. further studied 64
patients with HFpEF, and Tamanna et al. investigated CAD
(n = 50).8–10,17,29
Meta‐analysis results for disease
From the 27 eligible studies, five primary patient cohorts
were recruited: HFpEF, HFrEF, CAD, AS, and MR. Further-
more, 11 studies did not specify diagnoses, grouped into ‘het-
erogeneous’ for the purpose of this meta‐analysis.
The pooled analysis across all cohorts revealed a modest
association between echocardiographic and invasive haemo-
dynamic assessment (r = 0.64, 95% CI 0.56–0.71, P < 0.01,
z = 11.9) (Figure 5, Supporting Information, Table S6).
In total, 1055 patients were categorized as ‘heteroge-
neous’, and this group demonstrated the best association
with the least effect size (r = 0.73, 95% CI 0.70–0.76) and
highest weighting (22.16%). A small proportion of these pa-
tients were intubated in intensive care (n = 160). HFpEF
(r = 0.59, 95% CI 0.53–0.64, n = 575) patients were found to
have a lower correlation coefficient than HFrEF patients
(r = 0.67, 95% CI 0.61–0.72, n = 381). Patients recruited with
a diagnosis of CAD and MR demonstrated the lowest correla-
tion coefficient (r = 0.55, 95% CI 0.38–0.68, n = 91 and
r = 0.55, 95% CI 0.40–0.67, n = 108, respectively).
Clinical applicability (Critical Appraisal Skills
Programme) results
The modified CASP tool showed that 19% (n = 5) of studies
were ‘highly clinically applicable’, 56% (n = 15) ‘moderately
Table 1 Integrated equations identified in the literature for estimating left ventricular filling pressure
Abbreviation First author Year n Approach Disease state
E1 Gonzalez‐Vilchez 1999 54 10
3
/([2·IVRT] + FPV) Heterogeneous
E2 Tamanna 2010 50 1.43 × DR + 1.32 × E/A  0.024 × DT + 0.02 × MLAV + 9.2 CAD
E3 Temporelli 2010 43 32.16 + (0.1045E) + (0.1345A) + (0.17 DT) + (4.95 E/A) HFrEF
E4 Nagueh 1997 125 1.91 + (1.24*E/e′) Heterogeneous
E5 Ommen 2000 100 11.96 + (0.596*E/e′) HFpEF + HFrEF
CAD, coronary artery disease; DR, deceleration rate; DT, deceleration time; FPV, flow propagation velocity; HFpEF, heart failure with pre-
served ejection fraction; HFrEF, heart failure with reduced ejection fraction; IVRT, isovolumetric relaxation time; MLAV, maximal left atrial
volume.
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clinically applicable’, and 26% (n = 7) ‘less clinically applica-
ble’. Of those ‘less clinically applicable’, most failed to report
bias or undertake suitable reproducibility assessments
(Supporting Information, Table S2). Three studies scored
100%; all evaluated a heterogeneous cohort.
Discussion
This systematic review and meta‐analysis found that
non‐invasive echocardiographic estimates of LVFP demon-
strate moderate association to invasive right heart catheteri-
zation. Five echocardiographic methods were evaluated,
highlighting the integrated approach as best correlated. How-
ever, evidence for the integrated approach lacked in all HF
phenotypes, particularly HFpEF. Of the single approaches,
LA strain showed promising results.
Principal findings
This meta‐analysis demonstrates that echocardiographic ap-
proaches to estimating LVFP are feasible and can be applied
clinically. However, there was significant heterogeneity in
both the quality of studies and their findings. Many studies
recruited a heterogeneous cohort of patients, which makes
it challenging to apply their methods to predict LVFP in
groups of HF patients.
In patients with MR, Kawase et al. demonstrated that LA
volume and function (minimum LAVi and KT index, a marker
of LV function) appears to have a better correlation to
invasive PCWP than E/e′.23 The main limitation was the poor
reproducibility for the novel KT index. In patients with AS, a
single small study demonstrated promising results for E/e′
(r = 0.72, 95% CI 0.47–0.86), but more evidence is needed
to predict LVFP in this cohort. We did not identify any study
that has developed personalized non‐invasive models in
either mitral stenosis or aortic regurgitation.
Patients with HFpEF represent the second largest group
where LVFP has been studied non‐invasively. The pooled cor-
relation with invasive LVFP was modest. Maeder et al. dem-
onstrated that E/e′ has a weak association to LVFP in
patients with HFpEF.19 Two other studies by Hummel et al.
and by Ommen et al. again confirmed a poor correlation of
LVEDP to E/e′.10,25 The only study showing promising correla-
tion and high clinical applicability within HFpEF was Obokata
et al. (r = 0.63, 95% CI 0.43–0.77, n = 50).26 They also identi-
fied the incremental role of non‐invasive stress E/e′ to im-
prove diagnostic sensitivity.
In HFrEF, the pooled correlation coefficient was much
stronger for clinical translation across five studies. However,
only one study demonstrated excellent clinical applicability
for estimating LVFP by an integrated equation focusing on
MIV profile (E3) (Temporelli et al.).29 The main limitation of
this proposed equation is that no validation via a multicentre
trial has been undertaken to support widespread clinical
adoption. Cameli et al. demonstrated a strong correlation
using LA strain parameters in HFrEF in a small study of 36 pa-
tients. In patients with CAD, the pooled association was only
modest, and both studies that specifically recruited CAD pa-
tients demonstrated only medium to limited clinical
applicability.
Figure 5 Forest plots of all the heart disease states in which echocardiography has been tested for non‐invasive estimation of left ventricular filling
pressure. It is worth noting that the heterogeneous group represented the most patients in the total meta‐analysis (40.6%).
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Further, our study is unique due to its prominent inclusion
of heterogeneous patient populations, consisting of a num-
ber of cardiac pathologies as well as patients with normal
LVFP. While the algorithm laid out in ASE/EACVI 2016 recom-
mendations excludes patients without cardiac pathologies,6
we decided a heterogeneous cohort better matches that
seen in clinical practice, where diagnoses are often unclear
at the time the algorithm is applied.34 This decision is sup-
ported by our finding that the most clinically applicable
methods comprised the heterogeneous cohorts.7–9,28 These
studies demonstrated good association and scored high on
the modified CASP. However, one of these studies was on
only intubated patients.7 Nonetheless, Nagueh et al. re-
cruited a combination of intubated and non‐intubated pa-
tients to derive their non‐invasive equation and overall,
demonstrated a high correlation coefficient of 0.87.8 How-
ever, overall, there is a lack of clarity of evidence in HFpEF pa-
tients supporting the routine clinical use of E/e′ as an
accurate estimate of LVFP.
Comparisons with other recent meta‐analyses
Sharifov et al. undertook a systematic review and
meta‐analysis of 24 studies investigating the correlation be-
tween invasive LVFP using non‐invasive E/e′ in patients with
HFpEF.35 However, there are differences between ours and
the Sharifov et al. work. Firstly, the majority of their included
studies did not perform simultaneous echocardiography and
right heart catheterization. Our study has addressed this is-
sue, with 26/27 of our included studies having simultaneous
investigation. Sharifov et al. concluded a lack of evidence
for a substantive correlation with E/e′, requiring further vali-
dation, and this statement is supported by our findings. Fur-
thermore, Nauta et al. also performed a systematic review
studying the correlation between echocardiographically esti-
mated and invasively measured LVFP in patients with HFpEF
and again found a modest correlation using the E/e′
method.36 This study further considered the prognostic rele-
vance of this, demonstrating improvements when using mul-
tiple parameters simultaneously. These conclusions
strengthen our findings on the utility of integrated ap-
proaches. These studies, however, are limited to HFpEF co-
horts. Our meta‐analysis has divided patients by a variety of
diagnoses, providing a broader view of the usefulness of
echocardiography in estimating LVFP in HF.
Context, implications for health policy, and future
research
It is clear that one single non‐invasive echocardiographic pa-
rameter cannot reliably estimate LVFP across all cardiovascu-
lar pathologies. Importantly, in HFpEF, where it is critically
important to have such a non‐invasive diagnostic tool, we
have very limited evidence to support any current single or
even integrated method by echocardiography. This
meta‐analysis supports previous publications calling for fur-
ther research to validate non‐invasive LVFP estimates in
HFpEF. Future studies should consider robust clinical valida-
tion including reproducibility tests, which was identified as
one of the reasons why some studies were less clinically ap-
plicable. When reporting correlation coefficients, the studies
should also report either bias or standard error, between
non‐invasive and invasive methods. In patients with HFrEF,
the evidence is much stronger, and a cautious approach to in-
form LVFP can be applied.
Limitations
In this systematic review and meta‐analysis, we did not in-
clude studies specifically looking at the diagnostic accuracy
of any echocardiographic metric or integrated equation on a
categorical scale. Hence, we did not report studies that have
performed sensitivity/specificity analysis. We did this inten-
tionally to investigate the true continuum of any
non‐invasive method vs. the reference invasive method. In
addition, this work did not evaluate the prognostic role of
non‐invasive echocardiographic parameters.
Conclusions
Pooled echocardiographic indices show moderate association
to invasively measured LVFP; however, this varies with car-
diovascular pathology. In HFpEF or valvular heart disease,
no single echocardiography measure offers a reliable esti-
mate of LVFP. In HFrEF patients, mitral inflow‐derived indices
demonstrate promise for routine clinical use. Most studies in-
cluded heterogeneous patient groups and thus cannot be ap-
plied to a precision medicine approach. Integrated methods
incorporating several echocardiographic metrics appear most
promising for estimating LVFP reliably but require further val-
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